Emerging Healthcare: Key inflection points in an uncertain world

Investing in small/micro-cap healthcare is challenging due to a lengthy and binary driven product cycle, which is punctuated with bouts of excessive share volatility. While a pure momentum strategy that rides on investor enthusiasm, knowledge of the timing and share impact of different catalysts (eg regulatory events, clinical trial readouts, commercial milestones, etc) creates an opportunity for investors to benefit from volatility around high-impact events. In this note, we highlight key catalysts expected before calendar year end across the emerging healthcare sector. Report attached